We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
Considerations for multi-product manufacturing facilities
30 Jan 2017 - Trishul Shah, Associate Director Business Development at PolyPeptide Laboratories Inc, reviews the considerations for the manufacture of active pharmaceutical ingredients at a multi-product facility.[…]
Read moreDesigning quality into therapeutic peptide manufacturing
1 Dec 2014 - The PolyPeptide Group has embraced quality by design and uses a risk based approach to develop, manufacture and commercialize peptide based therapeutics.[…]
Read moreProcess validation: Manufacturing peptide APIs
28 May 2014 - Trishul Shah of the Polypeptide Group overviews the steps involved in the life-cycle approach encouraged by the US FDA in API manufacture.[…]
Read moreControl strategies for synthetic therapeutic peptide APIs – Part II: Raw material considerations
2014 - I. Eggen, B. Gregg, H. Rode, A. Swietlow, M. Verlander, A. Szajek; BioPharm International, May 2014 Read more
Read moreControl strategies for synthetic therapeutic peptide APIs – Part III: Manufacturing process considerations
2014 - I. Eggen, B. Gregg, H. Rode, A. Swietlow, M. Verlander, A. Szajek; BioPharm International, 2014 Read more
Read moreControl strategies for synthetic therapeutic peptide APIs – Part I: Analytical consideration
2014 - By Aleksander Swietlow,Harold Rode,Anita Szajek,Michael Verlander,Ivo Eggen,Brian Gregg; BioPharm International, Apr 2014 Read more
Read moreThe ideal peptide plant
28 May 2013 - Dr Olivier Ludemann-Hombourger of PolyPeptide Laboratories France looks at the latest process trends in peptide manufacturing and key drivers for innovation.[…]
Read moreMeeting the growing demand for peptide therapeutics
2013 - SciBX Collection: Macrocycles and Constrained Peptides, Apr 2013 Read more
Read moreBioconjugates: The adaptable challenge
2013 - Trishul Shah, BioPharm International, January 2013 Read more
Read more